A distal enhancer that speci®es apolipoprotein E gene expression in the skin was identi®ed and characterized by in situ hybridization in transgenic mice generated with constructs of the human apolipoprotein E/C-I/C-IV/C-II gene cluster. Transgene constructs containing the enhancer expressed high levels of apolipoprotein E mRNA in the germinative cell layer of the sebaceous gland and in epithelial cells of the hair follicle root sheath. Apolipoprotein E mRNA was also detected in basal epithelial cells of the epidermis. Expression of the human apolipoprotein E transgene at these sites was speci®ed by a unique 1.0 kb enhancer domain located 1.7 kb downstream of the apolipoprotein E gene. No transgene expression was detected in skin epithelial cells in transgenic mice when this enhancer was deleted from the apolipoprotein E gene cluster. The enhancer was used to construct a transgene expression vector that faithfully directed a heterologous cDNA to the normal sites of apolipoprotein E gene expression in epithelial cells of the skin. Key words: apoE mRNA/ enhancer/epidermis/hair follicle/sebaceous gland/transgenic. J Invest Dermatol 116: 77±84, 2001 A polipoprotein E (apoE) (M r = 35,000) has multiple functions in lipid metabolism (Mahley, 1988; Mahley and Huang, 1999) . ApoE is a ligand for the family of low-density lipoprotein (LDL) receptor proteins and binds to heparan sulfate proteoglycans. Through these properties, apoE mediates the clearance of large remnant lipoproteins and apoE-rich high-density lipoproteins (HDLs) from plasma, thereby functioning in the redistribution of cholesterol and triglycerides between peripheral tissues and the liver. As much as 90% of plasma apoE is produced by the liver (Linton et al, 1991) , but the apoE gene is expressed at widely varying levels in speci®c cells of most tissues throughout the body (Elshourbagy et al, 1985) . The presence of either arginine or cysteine at residues 112 and 158 (Weisgraber et al, 1981) speci®es three common human apoE variants, E2, E3, and E4 (Zannis and Breslow, 1981; Sing and Davignon, 1985) , that alter apoE function. ApoE3 is the major variant in the normolipidemic human population. ApoE2 is defective in receptor binding and associated with type III hyperlipidemia and premature atherosclerosis (Mahley and Rall, 1999) . ApoE4 facilitates the formation of the amyloid plaques and neuro®brillary tangles characteristic of Alzheimer's disease, making it an important risk factor for this neurodegenerative disorder (Roses, 1994; Weisgraber et al, 1994; Masliah et al, 1996) .
Several studies have shown that apoE is produced by the skin. The skin was identi®ed as a major site of apoE mRNA in rodents (Elshourbagy et al, 1985; Simonet et al, 1991) , and rat skin slices synthesize and secrete apoE (Tarugi et al, 1991) . Disruption of the lipid permeability barrier in mice increases epidermal apoE mRNA levels (Jackson et al, 1992) . Mice lacking apoE develop cutaneous foam cells, and feeding these animals a high-fat diet results in pathologic skin lesions enriched in lipid-®lled macrophages (Feingold et al, 1995) . Isolated cultured human keratinocytes also secrete apoE (Gordon et al, 1989) . Immunohistochemical analysis of human skin samples revealed apoE within epidermal epithelial cells and at the basement membrane of the dermal-epidermal junction (Furumoto et al, 1998) . Immunoreactive apoE is a component of amyloid deposits in patients with cutaneous amyloidosis (Furumoto et al, 1998) . Although these observations suggest a link between apoE and skin disorders, a mechanism for this association is unknown, and animal models for its study are limited in number.
The human apoE gene is located on chromosome 19 at the 5¢ end of a 44 kb gene cluster that also contains the apoC-I, apoC-IV, and apoC-II genes, and the apoC-I¢ pseudogene (Allan et al, 1995a; 1995b) . In all tissues, apoE gene expression is controlled by cellspeci®c distal enhancers . In the absence of these enhancers, the proximal promoter cannot direct transcription of the apoE gene in any cell in vivo . Hepatocyte expression of apoE is controlled by two cell-speci®c enhancers located 15 and 26 kb downstream of the apoE gene Allan et al, 1997) . The most distal liver enhancer appears to have arisen from the evolutionary duplication of an 11 kb genomic fragment that generated the inactive apoC-I¢ pseudogene (Allan et al, 1997) . A preliminary RNase protection analysis of tissue extracts from transgenic mice generated with apoE gene constructs indicated that apoE expression in the skin is also controlled by a distal downstream enhancer . The location of this enhancer, however, the cell types in which it functions, and the possibility that more than one skin enhancer domain might exist have not previously been determined.
We report here on the localization of a unique cell-speci®c enhancer domain that directs expression of the human apoE gene at high levels in the cells of the germinative outer layer of sebaceous glands and in epithelial cells of the hair follicle root sheath. The enhancer also directs apoE expression in basal epithelial cells of the epidermis. No expression of apoE in the skin occurs in the absence of this enhancer. The enhancer is capable of directing expression of heterologous sequences to these sites, making it a potentially useful component of transgene vectors for targeting gene expression to the skin.
MATERIALS AND METHODS
Transgenic mice and constructs Transgenic mice (inbred FVB/N strain) were generated by standard techniques with constructs of the human apoE gene cluster (Fig 1) as described previously (Allan et al, 1995b) . Two to four independent founder lines were established for each construct, and F1 progeny were analyzed in each case: representative data for each construct are presented here. The 70 kb 198.KK cloned genomic fragment and the 10 kb HEG1 subfragment (Fig 1) have been described previously Allan et al, 1995a) . The 10 kb HESS1 subfragment was generated by SphI digestion of apoE gene cluster DNA. The 198.SA construct was generated by deleting the 1.0 kb fragment between HindIII sites, located 1.7 and 2.7 kb downstream of the apoE gene in the 198.KK clone, by recA-assisted restriction endonuclease (RARE) cleavage methods as described previously (Allan et al, 1997) . To make the HEG2.6 construct, a 2.6 kb fragment from the apoE/C-I intergenic region was generated by polymerase chain reaction extension of oligonucleotides corresponding to the intergenic region from 2.7 kb downstream of the apoE gene to the 3¢ end of the apoC-I promoter. The 2.6 kb fragment then was ligated to the 3¢ end of construct HEG.1.
To test skin enhancer activity, we modi®ed a transgene expression vector (Fan et al, 1994) constructed with sequences from the human apoE gene. The vector apoE gene sequences included 3.0 kb of 5¢¯anking sequence, the ®rst exon, the ®rst intron, and six nucleotides of the second exon ligated to a polylinker that serves as a cDNA insertion site. The cDNA site was followed by the 3¢ terminal 124 nucleotides of the human apoE gene fourth exon, and 112 nucleotides of 3¢¯anking sequence ligated to a polylinker into which the skin enhancer domain was inserted. Additional polylinker sites added to both ends of the construct permit insertion into and excision from plasmids. An enhanced green¯uorescent protein (GFP) cDNA (EGFP, Stratagene, La Jolla, CA) was inserted into the cDNA site to generate a basic reporter construct. To direct transgene expression to the skin, transgene vector pEGFPsk, the 1.0 kb HindIII fragment from the apoE/C-I intergenic region, was inserted into the 3¢ polylinker of the basic reporter construct.
Nucleotide sequences were evaluated by the ClustalW algorithm and the Pustell matrix algorithm in the MacVector software suite (Oxford Molecular, Beaverton, OR). The human involucrin promoter sequence was taken from GenBank AF085346. The human apoE gene cluster nucleotide sequences were taken from GenBank AF050154 and our own sequence analysis (data not shown).
In situ hybridization Skin samples from the tail and ear were excised, placed in 4% paraformaldehyde, incubated overnight at 4°C, and embedded in paraf®n; 7 mm sections were cut by rotary microtome, mounted on Superfrost Plus slides (Fisher, Pittsburgh, PA), and baked at 55°C for 30 min. After removal of paraf®n by two successive 10 min immersions in xylene, the tissue sections were rehydrated in a progressive series of 3 min washes in 100%, 90%, 70%, 50%, and 30% ethanol, followed by three successive 5 min immersions in phosphate-buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na 2 HPO 4 , 1.4 mM KH 2 PO 4 , pH 7.3). The sections were incubated in 20 mg per ml proteinase K (Boehringer Mannheim, Indianapolis, IN) in 50 mM Tris-HCl, pH 8.0, 5 mM ethylenediamine tetraacetic acid (EDTA), 150 mM NaCl for 15 min at 20°C; proteolytic activity was stopped by immersion for 10 min in 0.2% glycine in PBS. After rinsing in PBS for 5 min, tissues were ®xed in 4% paraformaldehyde for 5 min, rinsed in PBS for 5 min, and acetylated for 10 min with 0.25% acetic anhydride in 0.1 mM triethanolamine, pH 8.0. Tissue sections were rinsed for 5 min in PBS and dehydrated by 3 min washes in 30%, 50%, 80%, 95%, and 100% ethanol.
RNA probes complementary to nucleotides 492-783 of mouse apoE mRNA and 20-411 of human apoE mRNA were labeled with [a-33 P]UTP to a speci®c activity of at least 2 Q 10 4 Ci per mmol with an RNA transcription kit (Stratagene). Both antisense and sense probes were prepared and used. Labeled probes were puri®ed through Micro Bio-Spin 30 chromatography columns (BioRad, Hercules, CA).
Tissue sections were incubated with 2.0 Q 10 6 cpm of hybridization probe for 14-18 h at 42°C in 50% formamide, 300 mM NaCl, 5 mM EDTA, 1 Q Denhardt's solution (0.2% polyvinylpyrrolidone, 0.02% Ficoll, 0.02% bovine serum albumin), 10% dextran sulfate, 250 mg per ml salmon sperm DNA, 0.1 mg per ml tRNA, and 20 mM Tris, pH 8.0. Then they were incubated twice for 10 min each at 20°C in 2 Q salt sodium citrate (SSC) (30 mM NaCl, 3 mM sodium citrate) and 1.0 mM EDTA. After immersion for 1 h at 37°C in 500 mM NaCl, 10 mM Tris, pH 8.0, containing 20 mg per ml RNase A (Sigma, St. Louis, MO) and 10 units per ml T1 RNase (Boehringer Mannheim), the sections were washed at 55°C in six changes of 0.1 Q SSC containing 1.0 mM EDTA for 4 h, rinsed twice for 10 min each in 0.5 Q SSC, then dehydrated by 2 min progressive washes in 50%, 70%, and 90% ethanol containing 0.3 M ammonium acetate. The slides were dipped in NTB2 nuclear track emulsion (Kodak, Rochester, NY), incubated at 4°C for 5 d, and developed with D-19 developer (Kodak). The sections were stained with hematoxylin and eosin or methyl green as described previously and overlaid with coverslips. Hybridization of a probe to mRNA was detected by dark®eld microscopy. No signal was detected in the skin when a labeled sense probe was used for hybridization.
Cellular localization studies Immunocytochemistry was done with rabbit antihuman apoE essentially as described by Boyles et al (1985) . The antibody to human apoE was a gift from Dr. Karl Weisgraber (Gladstone Institute of Cardiovascular Disease). Sections expressing GFP were examined by¯uorescence microscopy at 480 nm, and potential auto¯uorescence was evaluated at 520 nm.
RESULTS
To identify the cells that expressed the human apoE gene in the skin, we performed in situ hybridization with a radioactive human apoE antisense probe on samples from transgenic mice generated with the 198.KK cloned human genomic fragment (Fig 1) . Dark- ®eld microscopy showed that the hybridization signal was concentrated most strongly over the germinative cells constituting the outer layer of sebaceous glands (Fig 2A) . A weak hybridization signal was detected in the basal epithelium of the epidermis.
To determine the location of the epithelial regulatory sequences, we investigated the ability of subfragments of the gene cluster (Fig 1) to direct apoE expression to the skin. No hybridization of the human antisense apoE probe was observed in skin sections from transgenic mice generated with the HEG1 subfragment (Fig 2B) , indicating that expression of the apoE gene in the skin is likely to be directed by enhancer sequences located further downstream. The lack of a signal also demonstrated that there was no signi®cant cross-hybridization of the human apoE mRNA probe to endogenous mouse apoE mRNA. Hybridization of the human apoE probe to skin from HESS1 transgenic mice gave a strong positive signal in sebaceous glands and hair follicle epithelium and a weaker signal in the basal epithelium of the epidermis (Fig 2C) .
The apoE mRNA signal in the epidermis varied in intensity (Fig 2A, C) , consistent with previously reported heterogeneity in the basal epithelial cell population (Milstone and LaVigne, 1985) . A similar ®nding has been reported recently in cells of the basal epithelial layer for the expression of genes that are under the control of the LEF family of DNA binding proteins (DasGupta and Fuchs, 1999) . The basis for this heterogeneity is unclear, but it may re¯ect transient differences in the proliferation potential of the basal epithelia (Jones, 1997), a property that may have features in common with the cyclic activation of hair follicle stem cells (Cotsarelis et al, 1990; Hardy, 1992) .
Transgene expression in the skin was con®rmed by immunocytochemical analysis of skin sections from HESS1 transgenic mice. Antibodies to human apoE showed immunoreactive apoE associated with the germinative cells at the outer layer of the sebaceous glands (Fig 3A) . An immunoreactive signal was detected in the epidermis as well, being most prominent in the spinous epithelial layer. No immune cross-reaction was detected between the antihuman apoE and endogenous mouse apoE in nontransgenic control mice (Fig 3B) .
The apoE/C-I intergenic region was examined further to localize the skin enhancer element. The presence of HindIII restriction endonuclease sites at 1.7 and 2.7 kb downstream of the apoE gene permitted the excision of this 1.0 kb fragment from the 198.KK genomic clone by the RARE cleavage method (Allan et al, 1997) to generate the 198.SA construct (Fig 1) . Analysis of skin from 198.SA transgenic mice by in situ hybridization showed no reaction of the human apoE antisense probe with sebaceous glands, hair follicle epithelium, or the epidermis (Fig 2D) . Similarly, the HEG2.6 construct that lacked the same 1.0 kb HindIII fragment but contained the remainder of the apoE/C-I intergenic region was not expressed in the skin (Fig 2E) . These results indicated that the skin enhancer was located in the 1.0 kb HindIII/HindIII portion of the intergenic region. Furthermore, the lack of a hybridization signal at these sites in the 198.SA transgenic mice indicated that no other skin enhancer was located within or near the human apoE gene cluster.
The location of the skin enhancer in the 1.0 kb HindIII/HindIII portion of the apoE/C-I intergenic region was con®rmed by preparing a transgene expression vector, pEGFPsk (Fig 4) , that used GFP as a sensitive reporter gene for ease of detection. Examination of skin from pEGFPsk transgenic mice by¯uorescence microscopy showed an intense signal in the sebaceous gland germinative cells and in the epithelial cells of both the inner and outer root sheath of the hair follicle (Fig 5A-C) . A somewhat weaker signal was observed in the epidermis. In the absence of the 1.0 kb HindIII intergenic fragment, the parent GFP expression vector was not expressed in any cells in the skin (data not shown).
The tissue speci®city of the apoE skin enhancer was investigated further by examining the potential expression of the EGFP transgene reporter construct in various tissues of transgenic mice generated with the pEGFPsk vector (Fig 4) . The highly sensitivē uorescence microscopy assay detected no GFP signal in any tissue examined other than skin and kidney (Fig 6) . Sections from submaxillary gland, lung, and choroid plexus were examined because of their relative enrichment in epithelial cells with distinctly different phenotypic properties. In the absence of the skin enhancer, the GFP reporter construct is not expressed in the skin (Fig 5D) . These results (Fig 6) and the data shown in Fig 5  and Fig 2 indicate that the activity of the apoE skin enhancer may be speci®c to epithelial cells in the germinative layer of the sebaceous glands and to cells in the basal and spinous layers of the epidermis.
In the absence of the skin enhancer, expression of the GFP reporter construct was observed in the kidney (Fig 6C) . Transgene expression was restricted to epithelial cells lining Bowman's capsule and a limited population of nearby tubules. This pattern of GFP transgene expression is essentially the same as that shown by the native HEG1 genomic fragment containing the intact human apoE gene with 5.3 kb of 5¢¯anking sequence and 1.7 kb of 3¢¯anking sequence (Fig 6I) . These results are consistent with our previous ®ndings in which we demonstrated that HEG1 expression occurs at high levels in only the epithelial cells lining Bowman's capsule and the proximal tubules (W Simonet 10809, W Simonet 8221). Our results here are consistent with the location of kidney enhancer activity in the proximal 5¢¯anking region of the apoE gene or within its ®rst intron. The skin enhancer is located more than 1.7 kb downstream of the apoE gene. The skin enhancer does not contribute to epithelial cell expression in the kidney nor does it direct transgene expression to epithelial cells in any other tissue examined.
DISCUSSION
Our results demonstrate that a single skin enhancer domain located 1.7 kb downstream of the apoE gene is solely responsible for directing expression of the apoE gene to the skin. No evidence for any other skin enhancer was found within a 70 kb cloned human genomic segment that included 5 kb of 5¢¯anking sequence upstream of the apoE gene, the entire apoE gene cluster, and 21 kb of 3¢¯anking sequence downstream of the apoC-II gene. In the absence of the enhancer, the apoE promoter was not transcriptionally active in the skin. The enhancer was most active in the germinative outer cell layer of sebaceous glands and in basal epithelial cells of the hair follicle root sheath. These sites of apoE production have not previously been reported.
We examined the nucleotide sequence of the 1.0 kb HindIII apoE gene skin enhancer domain in the apoE/C-I intergenic region. The 3¢ half contained an intact member of the 0.3 kb Alu repeat family¯anked by two partial Alu family repeated sequences (data not shown). The 5¢ half of the enhancer domain consisted of a unique sequence (Fig 7) that had no signi®cant homology to any other domain within the human apoE gene cluster as determined by sequence analysis with the ClustalW alignment and Pustell matrix algorithms. Similarly, no region homologous to the unique sequence in the 1.0 kb HindIII skin enhancer domain was detected in the known 17 kb sequence of the 5¢¯anking domain as reported in Genbank (data not shown). Our analysis of the 198.SA construct (Fig 2) suggested that no skin enhancer element is located within 21 kb of the 3¢¯anking domain of the gene cluster. Thus, the unique sequence located between 1.7 kb and 2.3 kb downstream of the apoE gene appears to be the only skin enhancer domain associated with the human apoE gene cluster.
ApoE mRNA is most abundant in the basal layer of the epidermis, a site that is relatively enriched in LDL receptors (Williams et al, 1987; Mommaas et al, 1991) . These receptors have a high af®nity for apoE (Mahley, 1988) , and they may function in the uptake of circulating interstitial lipoproteins. The HDLs constitute the predominant lipoprotein class in interstitial¯uid, and apoE is a principal component of the large HDLs in this¯uid (Vessby et al, 1987) . The suprabasal layer of cells in the epidermis has a reduced content of LDL receptors (Williams et al, 1987) . Compared with the basal layer, the suprabasal layer had less apoE mRNA but was Figure 3 . Immunocytochemical localization of human apoE in transgenic mouse skin. Tail skin from a HESS1 transgenic mouse (A) or control mouse (B) was reacted with an antibody to human apoE and then with a secondary antibody to detect the location of the antihuman apoE as described by Boyles et al (1985) . The presence of apoE as a result of transgene expression is indicated by a dark immunoprecipitate under bright-®eld microscopy. Scale bar: 200 mm. Skin components, including spinous epithelia (SE), basal epithelia (BE), and sebaceous glands (SG), are labeled. Panel I shows a section of the kidney from a transgenic mouse generated with the HEG1 construct that was examined by in situ hybridization and bright-®eld microscopy with a human apoE mRNA antisense probe as described in the text.
relatively enriched in immunoreactive apoE (Fig 3A) . This ®nding suggests that much of the newly synthesized apoE remains associated with the suprabasal epithelial layers where it may function to supply lipid components in response to a substantially increased need by differentiating keratinocytes. Our localization of apoE mRNA in the epidermis is consistent with the results of a previous RNase protection analysis of total RNA extracted from cultured keratinocytes that were derived from a human adult male (Barra et al, 1994) . These earlier studies concluded that basal epithelia are rich in apoE mRNA that is translated into secretable apoE protein. Our ®nding that abundant amounts of immunoreactive apoE are associated with spinous epithelia, however, appears to be in contrast with the earlier studies (Barra et al, 1994) , which reported that large cultured suprabasal epithelial cells contain substantial levels of apoE mRNA but are de®cient in apoE synthesis and secretion. This variance between our study of transgenic mice and the previous study of cultured cells may be a re¯ection of the differences in metabolic and regulatory signals likely to be acting on differentiating epithelia in in vivo and in vitro environments.
Mature keratinocytes had no detectable apoE mRNA or immunoreactive apoE protein. As epidermal cells mature into keratinocytes, LDL receptors are lost and there is an increase in the synthesis of endogenous lipids (Williams et al, 1987) , including ceramides and cholesterol, which become major components of the skin lipid barrier (Downing, 1992) . In the highly strati®ed environment of the skin, apoE may be important in delivering lipids for use in membrane assembly during cell division. Portions of these lipids may serve as substrates for the synthesis of various components of the surface lipid barrier. Consistent with this possibility is the observation that damage or removal of the lipid barrier results in an increase in epidermal apoE mRNA levels (Jackson et al, 1992) . Thus, apoE production may contribute to maintenance and replenishment of skin surface lipids. This effect may be indirect, with apoE supplying lipid to rapidly growing basal epithelium for subsequent utilization by keratinocytes in the synthesis of lipids that become part of the epidermal surface.
The distribution of apoE gene expression in the skin contrasts with that of the involucrin gene, a marker for large mature differentiated keratinocytes that is not expressed in small basal epithelia (Banks-Schlegel and Green, 1981; Watt and Green, 1981) . Both apoE and involucrin are expressed at abundant levels in suprabasal epithelia and in inner root sheath epithelia, however; and a 2.5 kb involucrin promoter construct has been used to target a heterologous transgene to these sites (Pelengaris et al, 1999) . To determine if this pattern of gene expression involved regulatory elements in common, we compared the nucleotide sequence of the apoE skin enhancer with that of the proximal 2.5 kb of the 5¢¯a nking region of the involucrin gene (Crish et al, 1998) . A sequence identity of~40% was found between the two enhancers that corresponded to nucleotides ±1951 and ±2404 upstream of the involucrin gene (Fig 7) . Although the sequence similarity is limited, the alignment is consistent with previous studies that reported that regulatory elements in the region between ±1951 and ±2473 upstream of the involucrin gene were required for its expression in the epidermis (Crish et al, 1998) . No involucrin expression in the skin occurred in the absence of this enhancer (Crish et al, 1998) . As the apoE and involucrin enhancers have regions of notable sequence homology, it is likely that common elements outlined by the larger shaded boxes in Fig 7 direct gene expression to the skin. No consensus currently exists, however, regarding the identity of any unique transcription factor or combination of factors that speci®es epithelial expression in this tissue (Byrne, 1997) . Functional tests remain to be performed to assess this possibility.
ApoE mRNA was detected at high levels in the germinative outer layer of the sebaceous glands, a layer of cells that also is in contact with interstitial¯uid. As these cells differentiate, their progeny are displaced into the inner layers of the gland, where they synthesize characteristic lipids of the sebum that are distinct from epidermal lipids (Stewart and Downing, 1991) . These sebaceous cells become larger and engorged with lipids. Sebaceous cells live about 5 d in rodents (Colton and Downing, 1985) ; when they die, cellular lipids are released into the sebum. As the sebum empties into the hair follicle, it acts as a dynamic seal around the hair shaft and contributes to body scent (Stewart and Downing, 1991) .
The action of apoE in delivering interstitial lipids to the sebaceous gland may be in a dynamic balance with the opposing action of apoC-I. Transgenic mice that overexpress apoC-I have cutaneous abnormalities, including atrophic sebaceous glands, reduced sebum production, partial hair loss, and scaly skin (Jong et al, 1998) . ApoC-I inhibits the binding of apoE to cell-surface receptors, thereby reducing apoE-mediated uptake of lipoproteins into cells (Weisgraber et al, 1990; Swaney and Weisgraber, 1994) . These observations suggest that delivery of apoE to sebaceous glands may be regulated and responsive to physiologic signals. Furthermore, impairment of apoE-mediated lipid delivery to sebaceous glands may lead to skin disorders that affect the protective nature of sebum.
The cellular locations of apoE mRNA in the skin suggest that a major function of apoE in this tissue is to deliver lipids for the accelerated production of new cells, which requires substantial amounts of new membrane synthesis. This possibility is consistent with the hypothesis that apoE plays a role in mobilizing membrane lipids during nerve regeneration (Boyles et al, 1990) , synaptic remodeling (Poirier, 1994) , and neurite outgrowth (Handelmann et al, 1992). The rapid growth of new cells in the germinative layer of sebaceous glands would be expected to create a high demand for new membrane lipids, and that is where the highest levels of apoE mRNA are found in the skin. Reduction in the apoE-mediated delivery of lipid to sebaceous glands would be expected to impair gland differentiation and the production of sebum. In the epidermis, the synthesis of apoE in basal epithelial cells would facilitate new cell membrane production, but intracellular metabolic requirements may also contribute to apoE production in this location (Barra et al, 1994) . In zebra-®sh, apoE mRNA is present at high levels in the epithelial cells of pectoral limb buds and median ®n fold during embryogenesis and in the basal cell layer of the epidermis at sites of ®n and scale development during ®n regeneration (Monnot et al, 1999) . These sites of synthesis support a role for apoE in tissue development.
ApoE may play a role in delivering lipid from interstitial lipoproteins to sebaceous glands and the epidermis for the synthesis of key components in the skin surface lipid barrier. It remains to be determined whether this effect of apoE is an indirect result of facilitating new cell production or a direct effect of supplying new lipid for endogenous lipid synthesis. Our ®ndings in this study indicate that apoE is a key mediator in the redistribution of cholesterol and other lipids in the skin that are essential for membrane remodeling and cell growth. Knowledge of the regulatory sequences that specify apoE expression at those sites and the availability of transgene expression vectors that target to those sites should help to elucidate the physiologic mechanisms that utilize apoE in the skin.
